Anyone who is suffering from mesothelioma or who has a loved one with the disease knows that the prognosis can be grim. However, medical research is ongoing, with treatments that can delay or even stop the disease being sought in the U.S. and around the world.
Many of the clinical trials and other research in the U.S. have been done with the support of the National Institutes of Health (NIH). Further, much of the funding for this research has come from the Department of Defense through the Congressionally Directed Medical Research Program (CDMRP). This program deals with multiple types of medical conditions, including numerous types of cancer.
Significant budget reductions
The federal government’s support has been crucial to helping medical professionals improve the lives of people with mesothelioma and work towards new and better treatments to prolong and improve their lives.
Therefore, there has been considerable concern about cuts to funding of many types of medical research carried out by universities and other research facilities announced this year by the current administration. Funding for the CDMRP was cut by 57% earlier this year compared to the prior year.
Funding for the NIH was also cut this year. Further, the White House has announced that it plans to reduce the NIH’s budget by approximately 40% ($18 billion) in 2026. It’s already lost some 3,000 employees.
Certainly, these cuts affect people with other medical conditions besides mesothelioma. However, breakthroughs in cancer and other types of research often help those with mesothelioma. Therefore, anything that slows it can have a significant short- and long-term effect, not just here in the U.S. but worldwide.
Those dealing with mesothelioma and other asbestos-related medical conditions should still seek the maximum compensation to which they’re entitled. This can help them better take advantage of current and future treatments, wherever they may be. Getting experienced legal guidance is the best first step.